Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease

NCT02612350 is registered in ClinicalTrials.gov with Pathway Genomics as lead sponsor.

NCT NCT02612350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
Lead sponsor
Pathway Genomics
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
August 31, 2017
Enrollment
1,106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mutation, neoplasms